Key result
Dual-chamber rate responsive pacing (DDDR-70) was associated with higher all-cause mortality than backup ventricular pacing (VVI-40) in patients with AICDs (19% vs 11%; p<0.01).
Why the study?
Does dual-chamber rate responsive pacing (DDDR-70) increase mortality compared to backup ventricular pacing (VVI-40) in patients with AICDs without indications for antibradycardia pacing?
Observational (n=535)
No
Does dual-chamber rate responsive pacing (DDDR-70) increase mortality compared to backup ventricular pacing (VVI-40) in patients with AICDs without indications for antibradycardia pacing?
Absolute Event Rate: 19% vs 11%
p-value: p=< .01
Dual-chamber rate responsive pacing (DDDR-70) is associated with significantly higher mortality than backup ventricular pacing (VVI-40) in AICD patients without antibradycardia pacing indications.
Caution advised with DDDR-70 in AICD patients without pacing indications; leaves open causal confirmation in randomized trials.
BACKGROUND: One study showed in 506 patients with automatic implantable cardioverter-defibrillators (AICDs) that the mortality at 1-year follow-up was 6.5% with ventricular backup pacing at 40/minute (VVI-40) versus 10.1% in patients with dual-chamber rate responsive pacing at 70/minute (DDDR-70). METHODS: We performed a retrospective study to determine all-cause mortality in all patients at a university hospital who had AICDs without indications for antibradycardia pacing. Of 535 patients, mean age 70 +/- 12 years, 271 patients had backup ventricular pacing with a VVI-40, and 264 patients had dual-chamber rate responsive pacing with a DDDR-70. RESULTS: At 3.7-year mean follow-up, all-cause mortality was 19% (50 of 264 patients) in patients with DDDR-70 pacing versus 11% (29 of 271 patients) with VVI-40 pacing (p < .01). CONCLUSION: Because of the increased mortality, increased cost, and complexity for dual-chamber rate responsive pacing in patients with AICDs, concomitant DDDR pacing at a rate of 70/minute in patients without an indication for antibradycardia pacing is not warranted.
No takes yet. Share an insight, caveat, or question.
Sukhija et al. (2005) conducted an observational in Automatic implantable cardioverter-defibrillators (AICDs) without indications for antibradycardia pacing (n=535). Dual-chamber rate responsive pacing (DDDR-70) vs. Backup ventricular pacing (VVI-40) was evaluated on All-cause mortality (p=< .01). Dual-chamber rate responsive pacing (DDDR-70) was associated with higher all-cause mortality than backup ventricular pacing (VVI-40) in patients with AICDs (19% vs 11%; p<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: